Case report highlights treatment challenges in papillary endometrial carcinoma, indicating aggressive nature of this uterine cancer.
Papillary endometrial carcinoma is a rare and aggressive form of uterine cancer, distinct from the more common endometrioid types. It occurs mainly in post-menopausal women, in the absence of hyperestrogenism. Histologically, it is characterized by a complex papillary architecture and marked nuclear atypia. Diagnosis is based on histology and immunohistochemistry, enabling differentiation from serous carcinoma. Treatment is based on a multimodal approach combining surgery, chemotherapy and sometimes radiotherapy. Due to its aggressive nature, the prognosis remains guarded, with a high risk of recurrence and metastasis. Recognition of this entity is helping to optimize management and steer research towards more targeted therapies.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: